NASDAQ:HYPR Hyperfine (HYPR) Stock Forecast, Price & News $2.01 +0.02 (+1.01%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$1.97▼$2.0650-Day Range$1.85▼$3.1752-Week Range$0.68▼$3.28Volume59,847 shsAverage Volume125,517 shsMarket Capitalization$143.41 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Hyperfine MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside74.1% Upside$3.50 Price TargetShort InterestHealthy3.02% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.63) to ($0.64) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.80 out of 5 starsMedical Sector773rd out of 965 stocksElectromedical Equipment Industry20th out of 22 stocks 3.5 Analyst's Opinion Consensus RatingHyperfine has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.50, Hyperfine has a forecasted upside of 74.1% from its current price of $2.01.Amount of Analyst CoverageHyperfine has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.02% of the float of Hyperfine has been sold short.Short Interest Ratio / Days to CoverHyperfine has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hyperfine has recently decreased by 2.74%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldHyperfine does not currently pay a dividend.Dividend GrowthHyperfine does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HYPR. Previous Next 0.0 News and Social Media Coverage MarketBeat FollowsOnly 2 people have added Hyperfine to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hyperfine insiders have not sold or bought any company stock.Percentage Held by Insiders26.50% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 12.88% of the stock of Hyperfine is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Hyperfine are expected to decrease in the coming year, from ($0.63) to ($0.64) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hyperfine is -2.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hyperfine is -2.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHyperfine has a P/B Ratio of 1.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Hyperfine (NASDAQ:HYPR) StockHyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products. Its products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care. The company was incorporated in 2014 and is based in Guilford, Connecticut.Read More HYPR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HYPR Stock News HeadlinesSeptember 12, 2023 | msn.comDown -21.28% in 4 Weeks, Here's Why Hyperfine, Inc. (HYPR) Looks Ripe for a TurnaroundSeptember 11, 2023 | msn.comDown -15.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Hyperfine, Inc. (HYPR)September 24, 2023 | Legacy Research (Ad)Watch SHOCKING Footage of AI Facility with Ties to Elon MuskI recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.September 7, 2023 | msn.comHyperfine, Inc. (HYPR) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerSeptember 7, 2023 | finance.yahoo.comHyperfine, Inc. to Present at Gilmartin Group Emerging Growth ShowcaseAugust 17, 2023 | msn.comHyperfine, Inc. (HYPR) Upgraded to Buy: Here's What You Should KnowAugust 15, 2023 | markets.businessinsider.comB.Riley Financial Reaffirms Their Buy Rating on Hyperfine (HYPR)August 14, 2023 | finance.yahoo.comHyperfine, Inc. Reports Second Quarter 2023 Financial ResultsSeptember 24, 2023 | Legacy Research (Ad)Watch SHOCKING Footage of AI Facility with Ties to Elon MuskI recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.August 13, 2023 | businesswire.comEnrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging ® SystemJuly 24, 2023 | finance.yahoo.comHyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023July 18, 2023 | finance.yahoo.comHyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating OfficerJuly 17, 2023 | nasdaq.comHyperfine (HYPR) ACTION PMR Study Targets Better Stroke CareJuly 11, 2023 | finance.yahoo.comHyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke CareJune 21, 2023 | fool.comHyperfine (NASDAQ: HYPR)June 8, 2023 | finance.yahoo.comHyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR EducationMay 18, 2023 | finance.yahoo.comHyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income CountriesMay 12, 2023 | markets.businessinsider.comB.Riley Financial Remains a Buy on Hyperfine (HYPR)May 11, 2023 | msn.comRecap: Hyperfine Q1 EarningsMay 11, 2023 | finance.yahoo.comHyperfine, Inc. Reports First Quarter 2023 Financial ResultsApril 20, 2023 | finance.yahoo.comHyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023April 4, 2023 | finance.yahoo.comBrain-Computer Interface Market [2023-2030] Size, Share, Growth, Demand, Sales, Trends, Competitive Landscape And Regional OutlookMarch 22, 2023 | finance.yahoo.comHyperfine, Inc. (HYPR) Interactive Stock Chart - Yahoo FinanceMarch 22, 2023 | markets.businessinsider.comHyperfine (HYPR) Gets a Buy from B.Riley FinancialMarch 21, 2023 | finance.yahoo.comHyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 20, 2023 | msn.comHyperfine's Earnings: A PreviewMarch 6, 2023 | finance.yahoo.comHyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023See More Headlines Receive HYPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter. Email Address HYPR Company Calendar Last Earnings8/14/2023Today9/24/2023Next Earnings (Estimated)11/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HYPR CUSIPN/A CIK1833769 Webhyperfine.io Phone866-796-6767FaxN/AEmployees136Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.50 High Stock Price Forecast$3.50 Low Stock Price Forecast$3.50 Forecasted Upside/Downside+74.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.70) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,160,000.00 Net Margins-500.89% Pretax Margin-500.89% Return on Equity-41.31% Return on Assets-37.92% Debt Debt-to-Equity RatioN/A Current Ratio13.42 Quick Ratio12.67 Sales & Book Value Annual Sales$6.81 million Price / Sales21.06 Cash FlowN/A Price / Cash FlowN/A Book Value$1.75 per share Price / Book1.15Miscellaneous Outstanding Shares71,350,000Free Float52,439,000Market Cap$143.41 million OptionableNot Optionable Beta0.73 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. R. Scott Huennekens CPA (Age 59)M.B.A., Exec. Chairman Comp: $1.29MMs. Maria Sainz (Age 57)CEO, Pres & Director Comp: $340.24kDr. Jonathan M. Rothberg Ph.D. (Age 59)Founder & Vice Chairman Comp: $51.37kDr. Khan M. Siddiqui M.D. (Age 50)Chief Medical Officer & Chief Strategy Officer Comp: $581.98kMr. Brett Hale (Age 49)Chief Admin. Officer, CFO, Chief Compliance Officer, Treasurer & Corp. Sec. Dr. Tom Teisseyre Ph.D.Chief Operating OfficerMore ExecutivesKey CompetitorsPixie Dust TechnologiesNASDAQ:PXDTSemler ScientificNASDAQ:SMLRFONARNASDAQ:FONRElectromedNYSE:ELMDAxoGenNASDAQ:AXGNView All CompetitorsInsiders & InstitutionsWells Fargo & Company MNSold 77,285 shares on 8/15/2023Ownership: 0.255%BlackRock Inc.Bought 26,462 shares on 8/11/2023Ownership: 1.004%Geode Capital Management LLCBought 4,762 shares on 8/11/2023Ownership: 0.596%Bank of New York Mellon CorpBought 12,764 shares on 8/3/2023Ownership: 0.076%Khan SiddiquiSold 1,735 sharesTotal: $2,168.75 ($1.25/share)View All Insider TransactionsView All Institutional Transactions HYPR Stock - Frequently Asked Questions Should I buy or sell Hyperfine stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" HYPR shares. View HYPR analyst ratings or view top-rated stocks. What is Hyperfine's stock price forecast for 2023? 1 equities research analysts have issued twelve-month price objectives for Hyperfine's shares. Their HYPR share price forecasts range from $3.50 to $3.50. On average, they expect the company's share price to reach $3.50 in the next twelve months. This suggests a possible upside of 74.1% from the stock's current price. View analysts price targets for HYPR or view top-rated stocks among Wall Street analysts. How have HYPR shares performed in 2023? Hyperfine's stock was trading at $0.84 at the beginning of the year. Since then, HYPR shares have increased by 139.3% and is now trading at $2.01. View the best growth stocks for 2023 here. When is Hyperfine's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our HYPR earnings forecast. How were Hyperfine's earnings last quarter? Hyperfine, Inc. (NASDAQ:HYPR) announced its earnings results on Monday, August, 14th. The company reported ($0.15) earnings per share for the quarter, beating analysts' consensus estimates of ($0.17) by $0.02. The firm earned $3.38 million during the quarter, compared to the consensus estimate of $2.60 million. Hyperfine had a negative trailing twelve-month return on equity of 41.31% and a negative net margin of 500.89%. What guidance has Hyperfine issued on next quarter's earnings? Hyperfine issued an update on its FY 2023 earnings guidance on Tuesday, August, 15th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $10.00 million-$14.00 million, compared to the consensus revenue estimate of $12.25 million. What is Hyperfine's stock symbol? Hyperfine trades on the NASDAQ under the ticker symbol "HYPR." Who are Hyperfine's major shareholders? Hyperfine's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (1.00%), Geode Capital Management LLC (0.60%), Wells Fargo & Company MN (0.26%) and Bank of New York Mellon Corp (0.08%). Insiders that own company stock include Alok Gupta, Hc Sponsor Llc, Jonathan M Rothberg, Khan Siddiqui, Maria Sainz and Neela Paykel. View institutional ownership trends. How do I buy shares of Hyperfine? Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Hyperfine's stock price today? One share of HYPR stock can currently be purchased for approximately $2.01. How much money does Hyperfine make? Hyperfine (NASDAQ:HYPR) has a market capitalization of $143.41 million and generates $6.81 million in revenue each year. The company earns $-73,160,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. How many employees does Hyperfine have? The company employs 136 workers across the globe. How can I contact Hyperfine? Hyperfine's mailing address is 55 HUDSON YARDS 28TH FLOOR, NEW YORK NY, 10001. The official website for the company is hyperfine.io. The company can be reached via phone at 866-796-6767 or via email at investors@hyperfine.io. This page (NASDAQ:HYPR) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.